Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Freya Biosciences ApS
APS
Active
Reklamebeskyttelse
CVR 41257547
Fruebjergvej 3, 2100
København Ø
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
17 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Freya Biosciences ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
CD
Colleen Denise Acosta
Chief Executive Officer
Chief Executive Officer
2020
MC
MBFH Consulting SAS
Founder
Founder
2020
Former (1)
RR
Randi Rich
Management
Management
2023 – 2023
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (6)
MS
Mark Smith
Board of Directors
Board of Directors
2020
CM
Claudia Maria Colciago
Board of Directors
Board of Directors
2023
NH
Nicholas Haft
Board of Directors
Board of Directors
2020
DL
David Lawrence Stern
Board of Directors
Board of Directors
2024
HE
Henrijette Elsebeth Richter
Board of Directors
Board of Directors
2020
PF
Peter Finsel Bisgaard
Chairman
Chairman
2020
Former (2)
TG
Thomas Gundelund Rasmussen
Board of Directors
Board of Directors
2020 – 2020
JE
Johannes Epeüs Theodoor van Hylckama Vlieg
Board of Directors
Board of Directors
2020 – 2020
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Sofinnova Capital X
Individual
15–19.99%
15–19.99%
2026
Danmarks Eksport- og Investeringsfond
Company
10–14.99%
10–14.99%
2024
Sofinnova Capital IX
Individual
10–14.99%
10–14.99%
2024
Bill & Melinda Gates Foundation
Individual
10–14.99%
10–14.99%
2025
OMX Ventures Fund I, LLC
Individual
10–14.99%
10–14.99%
2024
OMX Opportunity Fund I, LLC
Individual
5–9.99%
5–9.99%
2023
VÆKSTFONDEN
Company
5–9.99%
5–9.99%
2023
ABT Consult ApS
Company
5–9.99%
5–9.99%
2020
R. Rich Holding ApS
Company
5–9.99%
5–9.99%
2020
Curanthia Holdings ApS
Company
5–9.99%
5–9.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Freya Biosciences ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
